International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Clinical and Functional Outcome of Intra-articular Methylprednisolone Acetate in Knee Osteoarthritis: An Observational Study

Article Information

Volume / Issue7 / 3 (July-September 2026)
Pages268-274
AccessOpen Access

Publication Timeline

  • Received27 June 2026
  • Accepted25 July 2026
  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Background: Knee osteoarthritis (OA) is a common degenerative joint disorder and a major cause of pain, stiffness, and functional limitation in the elderly. Although multiple conservative treatment options are available, many patients continue to experience significant symptoms. Intra-articular corticosteroid therapy is widely used for short-term symptomatic relief because of its anti-inflammatory action and cost-effectiveness.
Objective: To study the clinical and functional outcome of intra-articular methylprednisolone acetate in patients with knee osteoarthritis, with specific evaluation of pain, stiffness, and functional status before and after treatment.
Methods: This observational study was conducted in the Department of Orthopaedics, Saraswathi Institute of Medical Sciences, Hapur, after institutional ethical approval and written informed consent. Eighty patients aged more than 50 years with primary knee OA of Kellgren–Lawrence grade II or above were included. Baseline assessment was done using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Patients received an intra-articular injection of 80 mg methylprednisolone acetate with 2% lignocaine through the superolateral patellar approach under strict aseptic precautions. Follow-up was performed at 4, 12, and 24 weeks. Data were analysed using the paired-sample t-test, and p < 0.05 was considered statistically significant.
Results: The mean age of participants was 64.84 ± 7.11 years, and females constituted 65.0% of the study population. WOMAC pain score improved from 15.03 ± 2.78 at baseline to 9.26 ± 2.35, 10.07 ± 2.45, and 11.66 ± 2.54 at 4, 12, and 24 weeks respectively. WOMAC stiffness score improved from 5.61 ± 1.11 to 3.50 ± 1.01, 3.91 ± 1.07, and 4.56 ± 1.05. WOMAC functional score improved from 47.39 ± 7.85 to 32.67 ± 5.54, 36.41 ± 5.96, and 41.60 ± 7.19. Total WOMAC score improved from 67.88 ± 8.69 at baseline to 45.33 ± 6.46, 50.20 ± 6.74, and 57.79 ± 7.99 at the respective follow-ups. All improvements were statistically significant (p < 0.001) compared with baseline. No patient was lost to follow-up, and no significant adverse effects were observed.
Conclusion: Intra-articular methylprednisolone acetate is a safe, effective, and economical treatment modality for knee osteoarthritis, providing significant short- to medium-term reduction in pain and stiffness with improvement in functional ability. Maximum therapeutic benefit was observed at 4 weeks, though statistically significant improvement persisted up to 24 weeks
 

References

  1. Saif ur Rehman SSU, Iqbal S, Shahid MU, Jahangir MS, Malik AL. Cartilage: structure, function, and the pathogenesis of osteoarthritis. In: Advancements in synovial joint science—structure, function, and beyond. IntechOpen; 2024. [Google Scholar][Crossref]
  2. Pal CP, Singh P, Chaturvedi S, Pruthi KK, Vij A. Epidemiology of knee osteoarthritis in India and related factors. Indian J Orthop. 2016;50(5):518-22. [Google Scholar][Crossref]
  3. Geng R, Li J, Yu C, Zhang C, Chen F, Chen J, et al. Knee osteoarthritis: current status and research progress in treatment. Exp Ther Med. 2023;26(4):1-11. [Google Scholar][Crossref]
  4. Li B, Yang Z, Li Y, Zhang J, Li C, Lv N. Exploration beyond osteoarthritis: the association and mechanism of its related comorbidities. Front Endocrinol (Lausanne). 2024;15:1352671. [Google Scholar][Crossref]
  5. Coaccioli S, Sarzi-Puttini P, Zis P, Rinonapoli G, Varrassi G. Osteoarthritis: new insight on its pathophysiology. J Clin Med. 2022;11(20):6013. [Google Scholar][Crossref]
  6. Batarfi WA, Yunus MHM, Hamid AA, Maarof M, Abdul Rani R. Breaking down osteoarthritis: exploring inflammatory and mechanical signaling pathways. Life (Basel). 2025;15(8):1238. [Google Scholar][Crossref]
  7. Vincent TL, Miller RE. Molecular pathogenesis of OA pain: past, present, and future. Osteoarthritis Cartilage. 2024;32(4):398-405. [Google Scholar][Crossref]
  8. Clunie G, Wilkinson N, Nikiphorou E, Jadon D. Oxford handbook of rheumatology. Oxford: Oxford University Press; 2018. [Google Scholar][Crossref]
  9. Eyles JP, Sharma S, Telles RW, Namane M, Hunter DJ, Bowden JL. Implementation of best -evidence osteoarthritis care: perspectives on challenges for, and opportunities from, low- and middle-income countries. Front Rehabil Sci. 2022;2:826765. [Google Scholar][Crossref]
  10. Zhu S, Qu W, He C. Evaluation and management of knee osteoarthritis. J Evid Based Med. 2024;17(3):675-87. [Google Scholar][Crossref]
  11. Testa G, Giardina SMC, Culmone A, Vescio A, Turchetta M, Cannavò S, et al. Intra-articular injections in knee osteoarthritis: a review of literature. J Funct Morphol Kinesiol. 2021;6(1):15. [Google Scholar][Crossref]
  12. Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT Jr. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol. 2019;15(2):77-90. [Google Scholar][Crossref]
  13. Joshi A, Gharib M. Steroids and corticosteroids. PM&R KnowledgeNow. 2024. [Google Scholar][Crossref]
  14. Stone S, Malanga GA, Capella T. Corticosteroids: review of the history, effectiveness, and adverse effects in treatment of joint pain. Pain Physician. 2021;24(S1):S233. [Google Scholar][Crossref]
  15. Salehi R, Valizadeh L, Negahban H, Karimi M, Goharpey S, Shahali S. WOMAC, Lequesne index, AIMS-SF, and VAS in knee osteoarthritis: responsiveness and minimal clinically important differences. Disabil Rehabil. 2023;45(13):2185-91. [Google Scholar][Crossref]
  16. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Criteria for classification of osteoarthritis of the knee. Arthritis Rheum. 1986;29(8):1039-49. [Google Scholar][Crossref]
  17. Ringdahl E, Pandit S. Treatment of knee osteoarthritis. Am Fam Physician. 2011;83(11):1287-92. [Google Scholar][Crossref]
  18. Dieppe P, Sathapatayavongs B, Jones H, Bacon P, Ring E. Intra-articular steroids in osteoarthritis. Rheumatology (Oxford). 1980;19(4):212-7. [Google Scholar][Crossref]
  19. Buyuk AF, Kilinc E, Camurcu IY, Camur S, Ucpunar H, Kara A. Comparative efficacy of intra-articular methylprednisolone and triamcinolone. Acta Ortop Bras. 2017;25(5):206-8. [Google Scholar][Crossref]
  20. Tian K, Cheng H, Zhang J, Chen K. Intra-articular methylprednisolone for pain in knee osteoarthritis: systematic review and meta-analysis. Medicine (Baltimore). 2018;97(15):e0240. [Google Scholar][Crossref]
  21. Pyne D, Ioannou Y, Mootoo R, Bhanji A. Intra-articular steroids in knee osteoarthritis: comparison of triamcinolone hexacetonide and methylprednisolone acetate. Clin Rheumatol. 2004;23(2):116-20. [Google Scholar][Crossref]
  22. Raynauld JP, Buckland-Wright C, Ward R, Choquette D, Haraoui B, Martel-Pelletier J, et al. Long-term intraarticular steroid injections in knee osteoarthritis: randomized double-blind trial. Arthritis Rheum. 2003;48(2):370-7. [Google Scholar][Crossref]
  23. Frizziero L, Pasquali Ronchetti I. Intra-articular treatment of knee osteoarthritis: comparison between sodium hyaluronate and methylprednisolone acetate. J Orthop Traumatol. 2002;3(2):89-96. [Google Scholar][Crossref]
  24. Kikkuri RR, Kashyap V, Upadhay A, Kumar V, Reddy KS, Singhal R. Effect of intra-articular corticosteroid injection in knee osteoarthritis: hospital-based cross-sectional study. J Pharm Bioallied Sci. 2021;13(Suppl 2):S1162-7. [Google Scholar][Crossref]
  25. Bensa A, Albanese J, Boffa A, Previtali D, Filardo G. Intra-articular corticosteroid injections provide clinically International Journal of Medical and All Body Health Research www.allmedicaljournal.com relevant benefit only at short-term follow-up in knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2024;32(2):311-22. [Google Scholar][Crossref]
  26. Trueba Davalillo CA, Trueba Vasavilbaso C, Navarrete Alvarez JM, Coronel Granado P, Garcia Jimenez OA, Gimeno del Sol M, et al. Clinical efficacy of intra-articular injections in knee osteoarthritis: randomized study comparing hyaluronic acid and betamethasone. Open Access Rheumatol. 2015;7:9-18. [Google Scholar][Crossref]

How to Cite

Yadav, A., Bhatia, R., & Sahu, R. L. (2026). Clinical and Functional Outcome of Intra-articular Methylprednisolone Acetate in Knee Osteoarthritis: An Observational Study. International Journal of Medical and All Body Health Research, 7(3), 268-274. https://doi.org/10.54660/IJMBHR.2026.7.3.268-274

Yadav, Abhinav, et al. "Clinical and Functional Outcome of Intra-articular Methylprednisolone Acetate in Knee Osteoarthritis: An Observational Study." International Journal of Medical and All Body Health Research, vol. 7, no. 3, 2026, pp. 268-274. https://doi.org/10.54660/IJMBHR.2026.7.3.268-274.

Yadav, A., Bhatia, R. and Sahu, R. L. (2026) 'Clinical and Functional Outcome of Intra-articular Methylprednisolone Acetate in Knee Osteoarthritis: An Observational Study', International Journal of Medical and All Body Health Research, 7(3), pp. 268-274. doi: 10.54660/IJMBHR.2026.7.3.268-274.

Yadav A, Bhatia R, Sahu RL. Clinical and Functional Outcome of Intra-articular Methylprednisolone Acetate in Knee Osteoarthritis: An Observational Study. International Journal of Medical and All Body Health Research. 2026;7(3):268-274. doi:10.54660/IJMBHR.2026.7.3.268-274

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.